Question 1: Define randomisation and outline the three reasons why randomisation is an important design element in trials assessing interventions Question 2: Define allocation concealment and discuss how it differs from blinding. Question 3: Define and discuss intention to treat analysis and why is it the preferred mode of analysis in trials compared to other types of analysis. Question 4: Define, compare and contrast pragmatic and explanatory trials. Explain why a pragmatic trial might be more useful than an explanatory trial. Altman, D. G., & Schulz, K. F. (2001). Statistics notes: Concealing treatment allocation in randomised trials. BMJ, 323(7310), 446-447. doi:10.1136/bmj.323.7310.446 Full text Day, S. J., & Altman, D. G. (2000). Statistics notes: Blinding in clinical trials and other studies. BMJ, 321(7259), 504. doi:10.1136/bmj.321.7259.504 Full text Detry, M. A., & Lewis, R. J. (2014). The intention-to-treat principle: How to assess the true effect of choosing a medical treatment. JAMA, 312(1), 85-86. doi:10.1001/jama.2014.7523 Full text Fergusson, D., Aaron, S. D., Guyatt, G., & Hebert, P. (2002). Post-randomisation exclusions: The intention to treat principle and excluding patients from analysis. BMJ, 325(7365), 652-654. doi:10.1136/bmj.325.7365.652 Full text Gore, S. M. (1981). Assessing clinical trials--Why randomise? British Medical Journal, 282(6280), 1958-1960. doi:10.1136/bmj.282.6280.1958 Full text Godwin, M., Ruhland, L., Casson, I., MacDonald, S., Delva D, Birtwhistle, R., … Seguin, R. (2003). Pragmatic controlled clinical trials in primary care: The struggle between external and internal validity. BMC Medical Research Methodology, 3, 28. doi:10.1186/1471-2288-3-28 Full text Hollis, S., & Camplbell, F. (1999). What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ, 319, 670-674. http://dx.doi.org/10.1136/bmj.319.7211.670 Full text Roland, M., & Torgerson, D. J. (1998). Understanding controlled trials: What are pragmatic trials? BMJ;316, 285. Full text Schulz, K. F. (1995). Subverting randomization in controlled trials. JAMA, 274(18), 1456-1458. doi:10.1001/jama.1995.03530180050029 Full text Schulz, K. F., & Grimes, D. A. (2002). Generation of allocation sequences in randomised trials: Chance, not choice. Lancet, 359(9305), 515-519. doi:10.1016/s0140-6736(02)07683-3 Full text Sedgwick, P. (2012). Confidence intervals and statistical significance. BMJ, 344, e2238. doi:10.1136/bmj.e2238 Full text Sedgwick, P. (2013). Allocation concealment versus blinding in randomised controlled trials. BMJ, 347, f5518. http://dx.doi.org/10.1136/bmj.f5518 Full text Sedgwick, P. (2014). Explanatory trials versus pragmatic trials. BMJ, 349, g6694. http://dx.doi.org/10.1136/bmj.g6694 Full text Sedgwick, P. (2014). Randomised controlled trials: balance in baseline characteristics. BMJ, 349, g5721. http://dx.doi.org/10.1136/bmj.g5721